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Abstract The purpose of this study was to determine the
prevalence of acquired antimicrobial resistance in Strepto-
coccus pneumoniae isolated from nasopharyngeal swabs
and blood and cerebrospinal fluid (CSF) specimens of
3,028 children hospitalized with signs or symptoms of
pneumonia, sepsis, or meningitis in rural Philippines
between 1994 and 2000. Pneumococci were identified
using standard methods, serotyped, and their susceptibility
to oxacillin, erythromycin, tetracycline, chloramphenicol,
and trimethoprim-sulfamethoxazole was determined using
the disk diffusion method. Penicillin minimum inhibitory
concentrations (MICs) of the oxacillin-resistant isolates
were further tested. The clonality of the penicillin-non-
susceptible (PNSP) isolates was analyzed using pulsed-field
gel electrophoresis (PFGE) and multi-locus sequence
typing (MLST). Altogether 1,048 isolates were analyzed,
of which 35 were invasive and 1,013 nasopharyngeal
isolates. None was resistant, but 22 (2.1%) were interme-
diately resistant to penicillin, 4 (0.2%) were resistant to
chloramphenicol, 3 (0.2%) to erythromycin, 39 (3.7%) to
tetracycline, and 4 (0.2%) to trimethoprim/sulfamethoxa-
zole. Twelve of the 22 PNSP isolates were of serotype 14
and of sequence type 63. These included the two invasive
PNSP isolates. PFGE profiling further identified three
separate clusters among the sequence of type 63, serotype
14 (ST6314) isolates. Antimicrobial resistance in both
invasive and nasopharyngeal pneumococcal pediatric iso-
lates in rural Philippines is rare. In spite of this remote
setting, the PNSP isolates of the serotype 14 clusters were
of ST63 type, which has been described previously on other
continents.
Introduction
Streptococcus pneumoniae, the pneumococcus, is among
the most important human bacterial pathogens as well as a
common component of the normal nasopharyngeal micro-
flora. It causes both mild upper respiratory infections like
otitis media or sinusitis, and severe diseases like pneumo-
nia, meningitis, and sepsis, especially in children. Pneumo-
nia is the most common cause of death in children under
5 years of age in developing countries, and the pneumo-
coccus its most important causative agent [1]. Resistance of
pneumococcus to penicillin and to other antibiotics has
been increasing worldwide [2, 3] and threatens the
successful management of pneumococcal disease using
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early antimicrobial therapy, the main preventive strategy
recommended by the World Health Organization (WHO)
[4].
A generally accepted cause of the increasing frequency
of antibiotic resistance is the profuse and inappropriate use
of antmicrobial agents [5, 6]. In the Philippines, antibiotics
are usually purchased over the counter without prescription
and the choices and doses are often inappropriate [7]. The
free over-the-counter availability of antibiotics has been
shown to be reflected in common pre-admission antibiotic
treatment in hospitalized patients [8, 9]. Against this
background, the results of our present study in the
Philippines are surprising. We studied the antimicrobial
susceptibility among a large set of pneumococcal isolates
from children under 5 years of age hospitalized for
pneumonia, meningitis, and sepsis, and found an unexpect-
edly low frequency of strains with decreased susceptibility
to penicillin, and no fully penicillin-resistant strains at all.
However, a slightly increasing trend in the prevalence of
penicillin-nonsusceptible pneumococci (PNSP) was ob-
served, most likely due to the spreading of one internation-
ally known pneumococcal clone that seems to express
various serotypes and penicillin susceptibility patterns on
other continents [10].
Materials and methods
Study site and preparation
Bohol in the Central Philippines is chiefly a rural area
with agriculture as its principal source of livelihood. In
the coastal areas, fishing is the main source of living. Of the
total of one million inhabitants, about 66,000 live in the
provincial capital Tagbilaran City, and the rest in small
towns or rural villages. The infant mortality rate in the area
is 28 per 1,000 live births, and pneumonia is considered the
main health problem of children [11]. The Governor
Celestino Gallares Memorial Hospital (Gallares Hospital)
is a 250-bed tertiary care government hospital located in
Tagbilaran City. In February 1994, preparations were
started to establish a study site for acute respiratory
infections (ARI) in Bohol, as a joint ARIVAC project of
the Gallares Hospital, of the Research Institute for Tropical
Medicine (RITM), Metro-Manila, the Philippines, the
National Public Health Institute (KTL), Helsinki and Oulu,
Finland, and the University of Queensland, Brisbane,
Australia. This included the establishment of the ARIVAC
microbiological laboratory and training of the pediatric staff
at the Gallares hospital [12, 13]. The study protocol was
approved by the Institutional and Ethical Review Board of
the RITM. Parents/guardians of enrolled patients were
requested to sign before admission the Gallares Hospital
Form for Authorization for Medical and/or Surgical
Treatment.
Patients
From April 1994 to June 2000, 3,028 children under 5 years
of age with severe or very severe pneumonia [4], suspected
meningitis, or suspected sepsis [12] were enrolled. Blood
and nasopharyngeal swab samples were obtained from all
the patients and cerebrospinal fluid (CSF) specimens when
indicated.
Bacteriological procedures
Blood, CSF, and nasopharyngeal swab samples were
cultured in the ARIVAC laboratory as described earlier
[12]. In brief, all invasive isolates from blood and CSF
were identified using generally accepted methods. The
isolates were stored in STGG [14] at −20°C for a maximum
of 1 month, after which they were sent in dry ice to the
RITM for confirmation, further tests, and long-term storage
at −80°C. From nasopharyngeal swab cultures only
pneumococci were sought using gentamicin blood agar
[12], identified, and sent to the RITM as described for
invasive isolates.
Pneumococcal isolates were serotyped using the capsular
Quellung test using serum pools and type-/group-specific
antisera obtained from the Statens Seruminstitut, Copenha-
gen, with quality assurance of all invasive isolates and 10%
of the nasopharyngeal isolates at the KTL, Oulu [15, 16].
Antimicrobial susceptibility was tested in the ARIVAC
laboratory using the disk diffusion method according to the
former National Committee for Clinical Laboratory Stan-
dards [17]. Mueller–Hinton agar was supplemented with
5% sheep’s blood. To test susceptibility to penicillin,
oxacillin disks (1 μg) were used. Other antibiotic disks
used were chloramphenicol (15 μg), tetracycline (30 μg),
erythromycin (15 μg), and trimethoprim/sulfamethoxazole
(1.25/23.75 μg; BBL, Cockeysville, MD, USA; Oxoid,
Basingstoke, Hampshire, England; and Difco, Franklin
Lakes, NJ, USA).
For all isolates showing decreased susceptibility in the
disk diffusion test, the minimum inhibitory concentration
(MIC) was determined using the E-test according to the
manufacturer’s instructions (AB Biodisk, Solna, Sweden).
The susceptibility results were analyzed using the WHO
NET computer program version 5.3 [18].
All PNSP isolates were analyzed using pulsed-field gel
electrophoresis (PFGE) to assess their genetic relatedness
[19]. A modification of the method of Matushek et al. was
used as a standard procedure for the preparation of bacterial
genomic DNA for PFGE analysis [20], which was
performed as described by de Lencastre and Tomasz [21].
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Restriction endonuclease SmaI (New England BioLabs,
Ipswich, MA, USA) was used for digestion and the DNA
fragments were separated in a 1.2% PFGE-agarose gel with
a CHEF DRR III system (Bio-Rad, Hercules, CA, USA).
Gels were stained in 1 mcg/ml ethidium bromide solution
and photographed under UV light. Cluster analysis was
performed using the BioNumerics software package (Ap-
plied Maths, Austin, TX, USA). In addition, all PNSP
isolates were analyzed using multi-locus sequence typing
(MLST), slightly modified from previously described
protocols ([22–24] Bruno Pichon Health Protection Agen-
cy, London, UK, personal communication, 4 April 2006).
Briefly, bacterial genomic DNA was isolated with the
DNeasy Tissue kit (Qiagen, Hilden, Germany) and seven
housekeeping genes were partially amplified using PCR.
The PCR products were purified using the QiaQuick PCR
Purification kit (Qiagen) or Geneclean Turbo kit (Q-
BioGene, Aurora, OH, USA) and sequenced bidirectionally.
The sequences obtained were compared with the material in
the MLST database [10], according to which the sequence
types (STs) were assigned.
Results
Among the 3,028 study children, pneumococci were
isolated in 1,367 (45%) of the nasopharyngeal samples
(carriage isolates) and 40 (1.3%) from blood or CSF
samples (invasive isolates). All of the pneumococcal
bacteremias were monobacterial. One carriage and one
invasive, if existent, isolate per patient were included in the
study. Due to accidental defrosting of the storage freezer at
the RITM in 2000, some of the isolates were lost before
testing was complete. Consequently, serotype and antimi-
crobial susceptibility results are now available for only 35
invasive and 1,013 nasopharyngeal isolates, and these form
the material of the present study.
Of the 1,048 pneumococcal isolates, 42 (4.0%) were
resistant to oxacillin in the disk diffusion test. These
isolates were then tested using the penicillin E-test, and
22 (2.1%) of them were confirmed to be of decreased
susceptibility to penicillin (MIC: 0.125–0.25 mg/L). Two of
these PNSPs were invasive and 20 were nasopharyngeal
isolates (Table 1). In the first 2 years of the study, only 2
PNSPs (0.9%) were found among the 218 isolates tested. In
the following 4 years the PNSPs showed a modest increase
to 2.4% of the 754 isolates tested, but in the final half-year
no PNSPs were found among the 76 isolates.
Among the 1,013 nasopharyngeal isolates, 4 were
resistant to chloramphenicol, 3 to erythromycin, 37 (3.6%)
to tetracycline, and 4 to trimethoprim/sulfamethoxazole.
Two (5.7%) of the 35 invasive isolates were resistant to
tetracycline.
Among the 22 PNSP isolates, ten of the nasopharyngeal
isolates and both of the invasive isolates were of serotype
14. Five of the remaining 10 PNSP nasopharyngeal isolates
were noncapsulated and the serotypes of the remaining 5
were 23F (two isolates), 4, 5, and 28. All of the 12 PNSP
serotype 14 isolates were resistant to tetracycline (MIC: 32–
64 mg/L). Among the remaining serotype 14 PNSP
isolates, this resistance pattern was found in only the one
PNSP isolate with serotype 28.
The PFGE profiling of the 12 serotype 14 PNSP isolates
revealed three clusters (Fig. 1): cluster A (patterns 994,
1720, and 2118 to 2552b), cluster B (patterns 1969 to
2070), and cluster C (patterns 1867 and 1932). Both of the
invasive isolates (2118b and 2552b), as well as the
nasopharyngeal isolates from the same patients (2118 and
2552), belonged to the major cluster A. The degree of
similarity within the clusters was 100%. The remaining one
Table 1 Annual incidences and serotypes of invasive and carriage isolates of penicillin-nonsusceptible pneumococci (PNSP)
Year of isolation Number of isolates
All Penicillin-nonsusceptible pneumococcal isolates
Oxacillin-resistant according to disk diffusion Confirmed by MIC Serotypes (number of isolates)
Invasive Carriage Invasive Carriage Invasive Carriage
1994 102 0 3 0 1 5
1995 116 0 6 0 1 NC
1996 235 0 6 0 4 14 (2), 23F (1), NC (1)
1997 240 0 5 0 4 14 (2), 23F (1), NC (1)
1998 186 2 10 1 5 14 14 (5)
1999 93 2 8 1 5 14 4 (1), 14 (1), 28 (1), NC (2)
1–6/2000 76 0 0 0 0
Total 1,048 4 38 2 20
MIC, minimum inhibitory concentration; NC, noncapsulated
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serotype 14 PNSP isolate (1189) was closely (>85%)
related to the major cluster A. In addition to the three PFGE
clusters, the ten non-serotype 14 PNSP isolates represented
an individual PFGE profile each (data not shown). The
MLST results showed that all 12 of the serotype 14 PNSP
isolates of the three clusters defined by PFGE profiling
shared an identical sequence type, ST63. None of the
remaining ten PNSP isolates were alike according to MLST.
Among these ten isolates, ST361, ST771, and eight
previously undescribed STs were represented.
Discussion
This study is part of prospective surveillance of invasive
bacterial infections in children under 5 years of age in the
rural province of Bohol in the Central Philippines [12]. This
is the first large-scale study of pneumococcal antimicrobial
resistance in the Philippines. The patients came from the
small city of Tagbilaran and from the surrounding rural
municipalities, therefore representing a population different
from the urban populations in Metropolitan Manila, where
pneumococcal antibiotic resistance has been studied previ-
ously [25–27]. In these studies, 65 pediatric blood culture
isolates [24], 100 nasopharyngeal isolates from nonhospi-
talized children under 5 years of age [26], and 22 invasive
isolates [27] collected mainly in the 1990s were studied, 3,
2, and 6 of which were reported to be penicillin-non-
susceptible respectively.
The results of the present study show that resistance to
penicillin and other clinically important drugs is uncommon
in both invasive and nasopharyngeal isolates of pneumo-
cocci in the rural Filipino children. This low prevalence of
PNSP observed is in contrast to other reports from the
South East Asia. In Taiwan, Korea, Sri Lanka, Vietnam,
Singapore, and Thailand, 37–92% of pneumococcal naso-
pharyngeal strains from children under 5 years of age
attending daycare centers or outpatient clinics or hospital-
ized with acute respiratory infection, were penicillin-non-
susceptible [26, 28]. A lower prevalence of PNSP (13%)
was reported from China, Malaysia, and India, where the
number of pneumococcal isolates varied from 44 to 204 per
country [26]. Similar figures from these countries have also
been reported by others [29, 30]. A recent report of the
ANSORP indicates even higher resistance rates in invasive
pneumococci in most of the countries in the area of South
East Asia [27].
Differences in antibiotic policies between countries offer
an explanation for the varying frequencies of resistant
pneumococcal strains. In Europe in the 1990s, high
frequencies of penicillin-intermediate or -resistant strains
were observed in Spain (41.2%), France (42.3%), and
Hungary (36.2%), but considerably lower in the UK (9%),
Germany (4%) [31], Sweden (3–5%) [32], and Finland
(6%,) [33]. In Spain and Hungary, antibiotics are freely
available, whereas in the UK, Sweden, and Finland a
prescription is required. Thus, rational use of antibiotics
seems to prevent or at least hinder the appearance and
spread of antibiotic resistance [34]. Similar to elsewhere in
the Philippines, antibiotics are also available over the
counter in Bohol. According to patient histories, antibiotics
have often been given to seriously ill children before
admission to hospital [12]. Against this background, our
finding of a low prevalence of PNSP in Filipino children is
surprising. Without a study including a questionnaire for
the parents on pre-admission antimicrobial treatment of the
children and testing the urine antibacterial activity of the
hospitalized children, reasons for this finding can be only
Fig. 1 SmaI fragments of
pulsed-field gel electrophoresis
(PFGE) of the 12 serotype 14
penicillin-nonsusceptible Strep-
tococcus pneumoniae isolates
(lanes 994–2552b). Lanes λ,
molecular weight (kb) markers
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speculated upon. In the South East Asian studies referred to
above [25–30], the study population consisted of urban
children often attending daycare. Our study population
represents mostly a rural lifestyle where small children live
at home. It stands to reason that transmission of resistant
bacteria in a low-density population, such as in our study, is
less frequent than in dense urban populations, and this
could contribute to the low rate of resistance in our study
population.
Epidemiological analysis of PNSP strains in South East
Asia [26, 28, 35], as well as in the Americas [36, 37] and in
Europe [38], indicate that the major cause of high
prevalence of PNSP is due to the introduction and spread
of pandemic multi-resistant clones. According to the
nomenclature established by the Pneumococcal Molecular
Epidemiology Network (PMEN) [39], the Spain23F-1 and
Spain9V-3 multi-resistant clones are among the most
common and wide-spread, and often the main cause of
high prevalence of PNSP. While MLST is nowadays
considered the gold standard for typing pneumococci due
to its high resolution and ease of comparison, PFGE is
more sensitive in detecting subtle changes in the genome
[23]. Thus, the results achieved using the two methods
reported here are not contradictory. None of the PFGE or
MLST patterns of the PNSP isolates in our study resembled
any of the patterns of the international clones published by
PMEN [39]. However, 15 strains expressing five different
serotypes (14, 15A, 19A, 19F, 23F) in the MLST database
[10] are identical to the ST6314 PNSP isolates in this study.
The antibiotic susceptibility data are not available for all the
previously reported sequence type 63 isolates, but the
majority of them are intermediately resistant to penicillin
(MIC between 0.12–1 μg/ml). The earliest of these findings
is a serotype 15A strain isolated in Sweden in 1992 [40].
The ST6314 PNSP isolates were not present in the material
of the present study collected in 1994–1995, but were
regularly present among the isolates from 1996–1999,
consistent with its recent introduction into the population.
The question of the further spread of this clone cannot
unfortunately be answered because of the discontinuation
of the study in June 2000.
A good situation can rapidly turn worse. The introduc-
tion of a PNSP clone with the high ability to spread can
rapidly increase the proportion of resistant strains [41]. The
proportion of penicillin-intermediate or -resistant strains
increased in the United States from 6.6% in 1991–1992 to
33.5% in 1996–1997 [42] and to 43.6% in 1997 [43].
During the 1990s, the prevalence of multiply resistant
pneumococci increased by approximately 3% in a year in
the USA [44]. While resistance in pneumococci is often
associated with the pediatric serotypes, i.e., major serotypes
causing infections in young children [45] included in the
modern pneumococcal vaccines, it has been proposed that
vaccination could “clean the table” by eradicating the
pediatric PNSP [46]. However, pneumococcus is a highly
variable and versatile organism, and it is quite likely that
under selection pressure caused by vaccination, for example,
anomalous serotypes of common pediatric PNSP clones can
become prevalent and the resistance problem will continue.
This has already been reported from the US [47]. In our
study, the ST6314 PNSP isolates were more common among
the invasive isolates, in spite of their low numbers, than
among the carriage isolates. One reason for this might be
their ability to resist pre-hospitalization antimicrobial treat-
ment, which is likely to prevent growth of susceptible
pneumococci in blood cultures taken during admission.
Acknowledgements Members of the ARIVAC consortium who
contributed to this work are: Dr Socorro Lupisan, RITM, Manila,
Philippines, for directing the laboratory; Professor Helen Mäkelä,
KTL, Helsinki, Finland, for consulting ARIVAC laboratory work; Dr
Erma Abucejo-Ladesma, Gallares Hospital, Tagbilaran, Philippines,
for being in charge of clinical activities; medical technologists Gene
Baluran and Maria Felnore Girasol, Gallares Hospital, Tagbilaran,
Philippines, for laboratory work; medical technologist Tarja Kaijalainen,
KTL, Oulu, Finland, for quality assurance of serotyping of pneumococci.
We thank the parents of the children enrolled in this study without
whose support this study would not have been possible and other
members of the ARIVAC consortium for their contribution to the
project. In particular we express thanks to the ARIVAC laboratory and
RITM microbiology laboratory staff for laboratory work, the study
nurses for patient enrollment and follow-up and the staff of Gallares
Hospital, Bohol, for their contribution (the pediatric and emergency
room staff for patient enrollment and management, Dr. Juanita Arcay
for support in establishing the ARIVAC laboratory and acting as
liaison between the hospital and the ARIVAC project).
This publication made use of the Multi Locus Sequence Typing
website (http://www.mlst.net) at Imperial College London, developed
by David Aanensen and Man-Suen Chan and funded by the Wellcome
Trust.
This work was supported by grants from The Academy of Finland
(contract Nos. 2041057 and 5569), Directorate General Research of
the European Union (contract Nos. 18CT950025, IC18-CT97–0219,
and ICA4-CT1999–10008), the Public Health Research and Develop-
ment Committee (PHRDS) of the National Health & Medical
Research Council (MHMRC), Australia (Project No. 964161) and
the Finnish International Development Aid to Physicians for Social
Responsibility, Finland.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, W.C.H.E. Group
(2005) WHO estimates of the cause of death in children. Lancet
365:1147–1152
2. Felmingham D, White AR, Jacobs MR et al (2005) The Alexander
Project: the benefits from a decade of surveillance. J Antimicrob
Chemother 56 [Suppl S2]:i3–ii21
Eur J Clin Microbiol Infect Dis (2008) 27:929–935 933
3. Bruinsma N, Kristinsson KG, Bronzwaer S et al, on behalf of the
EARSS participants (2004) Trends of penicillin and erythromycin
resistance among invasive Streptococcus pneumoniae in Europe. J
Antimicrob Chemother 54:1045–1050
4. WHO, Management of the Young Child with an Acute Respira-
tory Infection (1990) World Health Organization: program for
control of acute respiratory infections. World Health Organization,
Geneva
5. Austin DJ, Kristinsson KG, Anderson RM (1999) The relation-
ship between the volume of antimicrobial consumption in human
communities and the frequency of resistance. Proc Natl Acad Sci
USA 96:1152–1156
6. Bronzwaer SLAM, Cars O, Buchholz U et al, participants in the
European Antimicrobial Resistance Surveillance System (2002) A
European study on the relationship of antimicrobial use and
antimicrobial resistance. Emerg Infect Dis 8:278–282
7. Lansang MA, Lucas-Aquino R, Tupasi TE et al (1990) Purchase
of antibiotics without prescription in Manila, the Philippines:
inappropriate choices and doses. J Clin Epidemiol 43:61–67
8. Sombrero L, Sunico ME, Quiambao B et al (1999) Reliability of
parental history of antibiotic use for Filipino children admitted
with acute lower respiratory tract infection. Am J Trop Med Hyg
60:397–399
9. Liu Y-C, Huang W-K, Huang T-S, Kunin CM (1999) Extent of
antibiotic use in Taiwan shown by antimicrobial activity in urine.
Lancet 354:1360
10. Multi Locus Sequence Typing home page, http://www.mlst.net,
accessed 15 May 2007
11. DHE Center (2000) Philippine health statistics. DHE Center,
Manila
12. Lupisan S, Herva E, Sombrero L et al (2000) Invasive bacterial
infections in a rural province in Central Philippines. Am J Trop
Med Hyg 62:341–346
13. Herva E, Sombrero L, Lupisan S, Arcay J, Ruutu P (1999)
Establishing a laboratory for surveillance of invasive bacterial
infections in a tertiary care government hospital in a rural
province in the Philippines. Am J Trop Med Hyg 60:1035–1040
14. Kaijalainen T, Ruokokoski E, Ukkonen P, Herva E (2004)
Survival of Streptococcus pneumoniae, Haemophilus influenzae
and Moraxella catarrhalis frozen in skim milk-tryptone-glucose-
glycerol medium. J Clin Microbiol 42:412–414
15. Sörensen U (1993) Typing of pneumococci by using 12 pooled
antisera. J Clin Microbiol 31:2097–2100
16. Herva E, Granat S, Mia Z, Ollgren J, Piirainen L, Mäkelä PH
(2006) Field evaluation of the chessboard modification for
serotyping of Streptococcus pneumoniae in a small laboratory in
Bangladesh. Am J Trop Med Hyg 74:863–867
17. National Committee for Clinical Laboratory Standards (1997)
Performance standards for antimicrobial disk susceptibility tests;
approved standard, 6th edn. NCCLS Document M2-A6, NCCLS,
Villanova
18. World Health Organization. Drug resistance, WHONET software,
http://www.who.int/drugresistance/whonetsoftware/en/
19. Tenover FC, Arbeit RD, Goering RV et al (1995) Interpreting
chromosomal DNA restriction patterns produced by pulsed-field
gel electrophoresis: criteria for bacterial strain typing. J Clin
Microbiol 33:2233–2239
20. Matushek MG, Bonten MJ, Hayden MK (1996) Rapid preparation
of bacterial DNA for pulsed-field gel electrophoresis. J Clin
Microbiol 34:2598–2600
21. De Lencastre H, Tomasz A (2002) From ecological reservoir to
disease: the nasopharynx, day-care centres and drug-resistant
clones of Streptococcus pneumoniae. J Clin Microbiol 50 [Suppl
2]:75–82
22. Birtles A, McCarthy N, Sheppard CL et al (2005) Multilocus
sequence typing directly on DNA from clinical samples and a
cultured isolate to investigate linked fatal pneumococcal disease in
residents of a shelter for homeless men. J Clin Microbiol
43:2004–2008
23. Enright MC, Spratt BG (1998) A multilocus sequence typing
scheme for Streptococcus pneumoniae: identification of clones
associated with serious invasive disease. Microbiology 144:3049–
3060
24. Enright MC, Knox K, Griffiths D, Crook DWM, Spratt BG (2000)
Molecular typing of bacteria directly from cerebrospinal fluid. Eur
J Clin Microbiol Infect Dis 19:627–630
25. Capeding MR, Sombrero LT, Lucero MG, Saniel MC (1994)
Serotype distribution and antimicrobial resistance of invasive
Streptococcus pneumoniae isolates in Filipino children. J Infect
Dis 169:479–480
26. Lee NY, Song JH, Kim S et al (2001) Carriage of antibiotic-
resistant pneumococci among Asian children: a multinational
surveillance by the Asian Network for Surveillance of Resistant
Pathogens (ANSORP). Clin Infect Dis 32:1463–1469
27. Song JH, Jung SI, Ko KS et al (2004) High prevalence of
antimicrobial resistance among clinical Streptococcus pneumoniae
isolates in Asia (an ANSORP study). Antimicrob Agents Chemo-
ther 48:2101–2107
28. Dejsirilert S, Overweg K, Sluijter M et al (1999) Nasopharyngeal
carriage of penicillin-resistant Streptococcus pneumoniae among
children with acute respiratory tract infections in Thailand: a
molecular epidemiological survey. J Clin Microbiol 37:1832–1838
29. Kim S-N, Kim S-W, Choi I-H, Pjo S-N, Rhee D-K (1996) High
incidence of multi-drug-resistant Streptococcus pneumoniae in
South Korea. Microb Drug Resist 2:401–406
30. Chion C-CC, Liu Y-C, Huang T-S et al (1998) Extremely high
prevalence of nasopharyngeal penicillin-resistant Streptococcus
pneumoniae in children in Kaohsiung, Taiwan. J Clin Microbiol
36:1933–1937
31. Felmingham D, Washington J, the Alexander Project Group
(1999) Trends in antimicrobial susceptibiity of bacterial respira-
tory tract pathogens—findings of the Alexander project 1992–
1996. J Chemother 11:5–21
32. Kihlström E, Normann B (1995) Occurrence of pneumococci with
resistance or decreased susceptibility to penicillin in southeast
Sweden. Scand J Infect Dis 27:489–494
33. Pihlajamaki M, Jalava J, Huovinen P, Kotilainen P, Finnish Study
Group for Antimicrobial Resistance (2003) Antimicrobial resis-
tance of invasive pneumococci in Finland in 1999–2000. Anti-
microb Agents Chemother 47:1832–1835
34. Melander E, Ekdahl K, Jonsson G, Molstad S (2000) Frequency
of penicillin-resistant pneumococci in children is correlated to
community utilization of antibiotics. Pediatr Infect Dis J 19:1172–
1177
35. Parry CM, Duong NM, Zhou J et al (2002) Emergence in Vietnam
of Streptococcus pneumoniae resistant to multiple antimicrobial
agents as a result of dissemination of the multiresistant Spain
(23F)-1 clone. Antimicrob Agents Chemother 46:3512–3517
36. Richter SS, Heilmann KP, Coffman SL et al (2002) The molecular
epidemiology of penicillin-resistant Streptococcus pneumoniae in
the United States, 1994–2000. Clin Infect Dis 34:330–339
37. Wolf B, Rey LC, Brisse S et al (2000) Molecular epidemiology
of penicillin-resistant Streptococcus pneumoniae colonizing
children with community-acquired pneumonia and children
attending day-care centres in Fortaleza, Brazil. J Antimicrob
Chemother 46:757–765
38. Bogaert D, Syrogiannopoulos GA, Grivea JN, de Groot R, Beratis
NG, Hermans PWM (2000) Molecular epidemiology of penicillin-
nonsusceptible Streptococcus pneumoniae among children in
Greece. J Clin Microbiol 38:4361–4366
39. McGee L, McDougal L, Zhou J et al (2001) Nomenclature of
major antimicrobial-resistant clones of Streptococcus pneumoniae
934 Eur J Clin Microbiol Infect Dis (2008) 27:929–935
defined by the pneumococcal molecular epidemiology network. J
Clin Microbiol 39:2565–2571
40. Sa-Leao R, Tomasz A, de Lencastre H (2001) Multilocus
sequence typing of Streptococcus pneumoniae clones with
unusual drug resistance patterns: genetic backgrounds and
relatedness to other epidemic clones. J Infect Dis 184:1206–
1210
41. Soares S, Kristinsson KG, Musser JM, Tomasz A (1993) Evidence
for the introduction of a multiresistant clone of serotype 6B
Streptococcus pneumoniae from Spain to Iceland in the late
1980s. J Infect Dis 168:158–163
42. Mufson MA (1998) Editorial response: penicillin-resistant Strep-
tococcus pneumoniae increasingly threatens the patient and
challenges the physician. Clin Infect Dis 27:771–773
43. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN (1998)
Pre valence of antimicrobial resistance among respiratory tract
isolates of Streptococcus pneumoniae in North America: 1997
results from the SENTRY antimicrobial surveillance program.
Clin Infect Dis 27:764–770
44. Mera RM, Miller LA, Daniels JJ, Weil JG, White AR (2005)
Increasing prevalence of multidrug-resistant Streptococcus pneu-
moniae in the United States over a 10-year period: Alexander
Project. Diagn Microbiol Infect Dis 51:195–200
45. Tomasz A (1997) Antibiotic resistance in Streptococcus pneumo-
niae. Clin Infect Dis 24 [Suppl 1]:585–588
46. Talbot TR, Poehling KA, Hartert TV et al (2004) Reduction in
high rates of antibiotic-nonsusceptible invasive pneumococcal
disease in Tennessee after introduction of the pneumococcal
conjugate vaccine. Clin Infect Dis 39:641–648
47. Farrell DJ, Klugman KP, Pichichero M (2007) Increased antimi-
crobial resistance among nonvaccine serotypes of Streptococcus
pneumoniae in the pediatric population after the introduction of 7-
valent pneumococcal vaccine in the United States. Pediatr Infect
Dis J 26:123–128
Eur J Clin Microbiol Infect Dis (2008) 27:929–935 935
